Other Species / Isoforms
  CSK (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsAIQAAWP
0 1
CSK (human) ______MsAIQAAWP S2-p
CSK (mouse) ______MSAIQAAWP S2
CSK (rat) ______MSAIQASWP S2
S10-p
AIQAAWPsGTECIAK
0 1
CSK (human) AIQAAWPsGTECIAK S10-p
CSK (mouse) AIQAAWPSGTECIAK S10
CSK (rat) AIQASWPSGTECIAK S10
Y18-p
GTECIAKyNFHGtAE
1 2
CSK (human) GTECIAKyNFHGtAE Y18-p
CSK (mouse) GTECIAKyNFHGTAE Y18-p
CSK (rat) GTECIAKYNFHGTAE Y18
T23-p
AKyNFHGtAEQDLPF
0 1
CSK (human) AKyNFHGtAEQDLPF T23-p
CSK (mouse) AKyNFHGTAEQDLPF T23
CSK (rat) AKYNFHGTAEQDLPF T23
K43-ub
LTIVAVTkDPNWYkA
0 1
CSK (human) LTIVAVTkDPNWYkA K43-ub
CSK (mouse) LTIVAVTKDPNWYKA K43
CSK (rat) LTIVAVTKDPNWYKA K43
K49-ub
TkDPNWYkAKNKVGR
0 1
CSK (human) TkDPNWYkAKNKVGR K49-ub
CSK (mouse) TKDPNWYKAKNKVGR K49
CSK (rat) TKDPNWYKAKNKVGR K49
Y64-p
EGIIPANyVQKREGV
0 6
CSK (human) EGIIPANyVQKREGV Y64-p
CSK (mouse) EGIIPANYVQKREGV Y64
CSK (rat) EGIIPANYVQKREGV Y64
K72-ub
VQKREGVkAGTkLSL
0 1
CSK (human) VQKREGVkAGTkLSL K72-ub
CSK (mouse) VQKREGVKAGTKLSL K72
CSK (rat) VQKREGVKAGTKLSL K72
K76-ub
EGVkAGTkLSLMPWF
0 3
CSK (human) EGVkAGTkLSLMPWF K76-ub
CSK (mouse) EGVKAGTKLSLMPWF K76
CSK (rat) EGVKAGTKLSLMPWF K76
K86-ub
LMPWFHGkITREQAE
0 1
CSK (human) LMPWFHGkITREQAE K86-ub
CSK (mouse) LMPWFHGKITREQAE K86
CSK (rat) LMPWFHGKITREQAE K86
Y97-p
EQAERLLyPPETGLF
0 2
CSK (human) EQAERLLyPPETGLF Y97-p
CSK (mouse) EQAERLLyPPETGLF Y97-p
CSK (rat) EQAERLLYPPETGLF Y97
S136-p
YRIMYHAsKLSIDEE
0 1
CSK (human) YRIMYHAsKLSIDEE S136-p
CSK (mouse) YRIMYHASKLSIDEE S136
CSK (rat) YRIMYHASKLSIDEE S136
K171-ub
CTRLIKPkVMEGtVA
0 2
CSK (human) CTRLIKPkVMEGtVA K171-ub
CSK (mouse) CTRLIKPKVMEGTVA K171
CSK (rat) CTRLIKPKVMEGTVA K171
T176-p
KPkVMEGtVAAQDEF
0 1
CSK (human) KPkVMEGtVAAQDEF T176-p
CSK (mouse) KPKVMEGTVAAQDEF T176
CSK (rat) KPKVMEGTVAAQDEF T176
Y184-p
VAAQDEFyRsGWALN
Upstream
1 42
Treatment
  • vanadate
CSK (human) VAAQDEFyRsGWALN Y184-p
CSK (mouse) VAAQDEFyRSGWALN Y184-p
CSK (rat) VAAQDEFYRSGWALN Y184
S186-p
AQDEFyRsGWALNMk
0 1
CSK (human) AQDEFyRsGWALNMk S186-p
CSK (mouse) AQDEFyRSGWALNMK S186
CSK (rat) AQDEFYRSGWALNMK S186
K193-ub
sGWALNMkELkLLQt
0 4
CSK (human) sGWALNMkELkLLQt K193-ub
CSK (mouse) SGWALNMKELKLLQT K193
CSK (rat) SGWALNMKELKLLQT K193
K196-ub
ALNMkELkLLQtIGk
0 5
CSK (human) ALNMkELkLLQtIGk K196-ub
CSK (mouse) ALNMKELKLLQTIGK K196
CSK (rat) ALNMKELKLLQTIGK K196
T200-p
kELkLLQtIGkGEFG
0 1
CSK (human) kELkLLQtIGkGEFG T200-p
CSK (mouse) KELKLLQTIGKGEFG T200
CSK (rat) KELKLLQTIGKGEFG T200
K203-ub
kLLQtIGkGEFGDVM
0 7
CSK (human) kLLQtIGkGEFGDVM K203-ub
CSK (mouse) KLLQTIGKGEFGDVM K203
CSK (rat) KLLQTIGKGEFGDVM K203
K218-ub
LGDYRGNkVAVkCIK
0 1
CSK (human) LGDYRGNkVAVkCIK K218-ub
CSK (mouse) LGDYRGNKVAVKCIK K218
CSK (rat) LGDYRGNKVAVKCIK K218
K222-ub
RGNkVAVkCIKNDAT
0 8
CSK (human) RGNkVAVkCIKNDAT K222-ub
CSK (mouse) RGNKVAVKCIKNDAT K222
CSK (rat) RGNKVAVKCIKNDAT K222
Y277-p
AKGSLVDyLRSRGRs
0 6
CSK (human) AKGSLVDyLRSRGRs Y277-p
CSK (mouse) AKGSLVDYLRSRGRs Y277
CSK (rat) AKGSLVDYLRSRGRS Y277
S284-p
yLRSRGRsVLGGDCL
0 3
CSK (human) yLRSRGRsVLGGDCL S284-p
CSK (mouse) YLRSRGRsVLGGDCL S284-p
CSK (rat) YLRSRGRSVLGGDCL S284
K329-ub
VSEDNVAkVSDFGLT
0 3
CSK (human) VSEDNVAkVSDFGLT K329-ub
CSK (mouse) VSEDNVAKVSDFGLT K329
CSK (rat) VSEDNVAKVSDFGLT K329
K337-ub
VSDFGLTkEASSTQD
0 3
CSK (human) VSDFGLTkEASSTQD K337-ub
CSK (mouse) VSDFGLTKEASSTQD K337
CSK (rat) VSDFGLTKEASSTQD K337
K347-ub
SSTQDTGkLPVkWTA
0 3
CSK (human) SSTQDTGkLPVkWTA K347-ub
CSK (mouse) SSTQDTGKLPVKWTA K347
CSK (rat) SSTQDTGKLPVKWTA K347
K351-ub
DTGkLPVkWTAPEAL
0 2
CSK (human) DTGkLPVkWTAPEAL K351-ub
CSK (mouse) DTGKLPVKWTAPEAL K351
CSK (rat) DTGKLPVKWTAPEAL K351
S364-p
ALREKKFsTKSDVWS
Upstream
Downstream
5 0
Effects on Modified Protein
  • enzymatic activity, induced
  • phosphorylation
Kinase, in vitro:
  • PKACA (human)
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • alprostadil
  • antibody
  • aripiprazole
  • cAMP_analog
  • IBMX
  • phorbol_ester
CSK (human) ALREKKFsTKSDVWS S364-p
CSK (mouse) ALREKKFSTKSDVWS S364
CSK (rat) ALREKKFSTKSDVWS S364
K393-ub
PYPRIPLkDVVPRVE
0 3
CSK (human) PYPRIPLkDVVPRVE K393-ub
CSK (mouse) PYPRIPLKDVVPRVE K393
CSK (rat) PYPRIPLKDVVPRVE K393
K404-ub
PRVEKGYkMDAPDGC
0 1
CSK (human) PRVEKGYkMDAPDGC K404-ub
CSK (mouse) PRVEKGYKMDAPDGC K404
CSK (rat) PRVEKGYKMDAPDGC K404
Y416-p
DGCPPAVyEVMkNCW
0 1
CSK (human) DGCPPAVyEVMkNCW Y416-p
CSK (mouse) DGCPPAVYEVMKNCW Y416
CSK (rat) DGCPPAVYDVMKNCW Y416
K420-ub
PAVyEVMkNCWHLDA
0 1
CSK (human) PAVyEVMkNCWHLDA K420-ub
CSK (mouse) PAVYEVMKNCWHLDA K420
CSK (rat) PAVYDVMKNCWHLDA K420
K444-ub
REQLEHIkTHELHL_
0 1
CSK (human) REQLEHIkTHELHL_ K444-ub
CSK (mouse) REQLEHIKTHELHL_ K444
CSK (rat) REQLEHIRTHELHL_ R444